For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Pediatrix Medical Group Inc (NYSE: MD) closed at $17.39 in the last session, down -2.69% from day before closing price of $17.87. In other words, the price has decreased by -$2.69 from its previous closing price. On the day, 1.41 million shares were traded. MD stock price reached its highest trading level at $17.88 during the session, while it also had its lowest trading level at $17.185.
Ratios:
We take a closer look at MD’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.35 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.67. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.74.
On September 26, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $14.
Deutsche Bank Upgraded its Sell to Hold on June 07, 2024, while the target price for the stock was maintained at $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 21 ’25 when Swift James D bought 18,530 shares for $16.63 per share.
ORDAN MARK S sold 27,600 shares of MD for $423,660 on Nov 13 ’24. The Director now owns 138,683 shares after completing the transaction at $15.35 per share. On Nov 13 ’24, another insider, ORDAN MARK S, who serves as the Director of the company, bought 27,600 shares for $15.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 1514393856 and an Enterprise Value of 1786129920. As of this moment, Pediatrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.51, and their Forward P/E ratio for the next fiscal year is 9.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.70. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.78 while its Price-to-Book (P/B) ratio in mrq is 1.81. Its current Enterprise Value per Revenue stands at 0.92 whereas that against EBITDA is 7.545.
Stock Price History:
The Beta on a monthly basis for MD is 1.20, which has changed by 0.14332676 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, MD has reached a high of $18.22, while it has fallen to a 52-week low of $11.84. The 50-Day Moving Average of the stock is 3.42%, while the 200-Day Moving Average is calculated to be 18.65%.
Shares Statistics:
According to the various share statistics, MD traded on average about 779.02K shares per day over the past 3-months and 669160 shares per day over the past 10 days. A total of 86.85M shares are outstanding, with a floating share count of 85.53M. Insiders hold about 1.79% of the company’s shares, while institutions hold 94.04% stake in the company. Shares short for MD as of 1760486400 were 2746734 with a Short Ratio of 3.53, compared to 1757894400 on 2393237. Therefore, it implies a Short% of Shares Outstanding of 2746734 and a Short% of Float of 4.4099998000000005.
Earnings Estimates
Pediatrix Medical Group Inc (MD) is presently subject to a detailed evaluation by 7.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.46, with high estimates of $0.49 and low estimates of $0.43.
Analysts are recommending an EPS of between $1.83 and $1.76 for the fiscal current year, implying an average EPS of $1.79. EPS for the following year is $1.83, with 7.0 analysts recommending between $1.93 and $1.71.
Revenue Estimates
According to 7 analysts,. The current quarter’s revenue is expected to be $476.44M. It ranges from a high estimate of $519.82M to a low estimate of $452.89M. As of. The current estimate, Pediatrix Medical Group Inc’s year-ago sales were $511.16MFor the next quarter, 7 analysts are estimating revenue of $481.84M. There is a high estimate of $513.5M for the next quarter, whereas the lowest estimate is $458.7M.
A total of 7 analysts have provided revenue estimates for MD’s current fiscal year. The highest revenue estimate was $1.96B, while the lowest revenue estimate was $1.85B, resulting in an average revenue estimate of $1.89B. In the same quarter a year ago, actual revenue was $2.01BBased on 7 analysts’ estimates, the company’s revenue will be $1.94B in the next fiscal year. The high estimate is $2.03B and the low estimate is $1.86B.
